Additionally, while the majority of GLP-1 receptor agonist prescribing occurs within the first 6 months after an individual’s first obesity-related visit, medication shortages, step therapy requirements, and prior authorizations may delay prescription date. Here, GLP1R is linked to obesity disorder.